Arcadia Biosciences and Bioceres Welcome Martin Mariani Ventura as General Manager for Verdeca Joint Venture
July 11 2018 - 4:00AM
Business Wire
-- Seasoned agribusiness executive to help
prepare drought tolerant soybeans for commercial launch --
Arcadia Biosciences, Inc. (Nasdaq: RKDA) and Bioceres S.A.,
today announced they have hired Martin Mariani Ventura as general
manager of Verdeca, a joint venture to develop, deregulate and
market soybean varieties with next generation agricultural
technologies.
Mariani Ventura is a seasoned agribusiness executive with nearly
20 years of experience in various roles, including business
strategy, product licensing and commercialization, sales, marketing
and research and development. Most recently he served with FMC
Quimica Argentina, where he managed the insecticide and herbicide
portfolio for the Southern Cone region of Latin America. Before
that, Mariani Ventura worked for both DuPont Argentina and Monsanto
Argentina, and earlier in his career, he worked with Bioceres.
While at Monsanto Argentina, Mariani Ventura was instrumental in
the launch of their Intacta insect resistant soybean trait in Latin
America South.
“Martin’s experience in product strategy, trait licensing and
commercializing new products will be invaluable as Verdeca prepares
for the launch of its HB4 drought tolerant soybeans,” said Raj
Ketkar, president and CEO of Arcadia. “We look forward to working
with him to build the capabilities needed to bring this important
trait to market.”
In multiple field trials, Verdeca’s HB4 soybeans have produced
stable and high yields under multiple stresses typically found in
soybean production areas, including drought and low-water
conditions. HB4 soybeans have undergone extensive testing,
including six seasons of multi-location field trials in Argentina
and the United States and two years of regulatory field trials.
Verdeca is currently working with partners to breed the HB4 trait
into elite soybean varieties.
“During the 2017-18 drought in Argentina, local soybean farmers
have lost an estimated five billion U.S. dollars of crop value
beyond what is normally lost due to sporadic drought conditions
every year, reminding all of us about the importance of developing
solutions to mitigate these adverse weather effects,” said Federico
Trucco, Bioceres’ CEO. “Verdeca’s HB4 technology is the only seed
technology available today that addresses this specific problem in
soybeans. Under Martin’s leadership, we hope to expedite the
delivery of this solution to local and regional farmers, through
proprietary as well as third party high yielding varieties.”
Arcadia and Bioceres formed Verdeca in 2012 with a goal of
deploying its soybean traits in all key world regions, beginning in
South America and North America, which makes up close to 80 percent
of the global soybean acres, and exporting to China, which is the
world’s largest importer of soybean products. Verdeca’s HB4 trait
has already been approved in Argentina and by the U.S. Food &
Drug Administration. Regulatory submissions are currently under
consideration by the U.S. Department of Agriculture and in Brazil
and China.
About Bioceres
Bioceres is a fully integrated agricultural biotechnology
company utilizing multiple technology platforms to develop and
commercialize products that enhance crop productivity and expand
feedstock applications. The company is owned by more than 250 of
South America’s largest growers. Bioceres is a major shareholder of
Rizobacter, INDEAR (Institute of Agricultural Biotechnology of
Rosario), and Bioceres Semillas. For more information visit
www.bioceres.com.ar.
About Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. (Nasdaq: RKDA) develops and markets
high-value food ingredients and nutritional oils that help meet
consumer demand for a healthier diet. Arcadia’s GoodWheat™ branded
ingredients deliver health benefits to consumers and enable
consumer packaged goods companies to differentiate their brands in
the marketplace. The company’s portfolio of agricultural traits are
being developed to enable farmers around the world to be more
productive and minimize the impact of agriculture on the
environment. For more information, visit www.arcadiabio.com.
About Verdeca
Verdeca, a U.S.-based joint venture between Bioceres and Arcadia
Biosciences, develops and deregulates soybean varieties with
next-generation agricultural technologies. Working in partnership
with South American growers, Verdeca aims to provide technologies
that help increase crop productivity, making more efficient and
sustainable use of land and water resources. For more information
visit www.verdeca.com.
Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Forward-looking statements are subject to risks and
uncertainties that could cause actual results to differ materially,
and reported results should not be considered as an indication of
future performance. These risks and uncertainties include, but are
not limited to: Arcadia’s and its partners’ and affiliates’ ability
to develop commercial products incorporating their traits, and
complete the regulatory review process for such products; Arcadia’s
compliance with laws and regulations that impact Arcadia’s
business, and changes to such laws and regulations; Arcadia’s
future capital requirements and ability to satisfy its capital
needs; and the other risks set forth in Arcadia’s filings with the
Securities and Exchange Commission from time to time, including the
risks set forth in Arcadia’s Annual Report on Form 10-K for the
year ended December 31, 2017 and other filings. These
forward-looking statements speak only as of the date hereof, and
Arcadia Biosciences, Inc. disclaims any obligation to update these
forward-looking statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180711005222/en/
Arcadia BiosciencesJeff Bergau,
+1-312-217-0419jeff.bergau@arcadiabio.comorBioceresLaura
Amelong, +54-341-4861100laura.amelong@bioceres.com.ar
Arcadia Biosciences (NASDAQ:RKDA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arcadia Biosciences (NASDAQ:RKDA)
Historical Stock Chart
From Apr 2023 to Apr 2024